Literature DB >> 16282712

Effect of thrombin on permeability of human epithelial cell monolayers.

Shuichiro Hayashi1, Kazuhiko Takeuchi, Shinya Suzuki, Takatsugu Tsunoda, Chikako Tanaka, Yuichi Majima.   

Abstract

Epithelial cells play an important role in maintaining the airway barrier, which is impaired in inflammatory conditions. Recently, thrombin was reported to be increased in the airway of patients with asthma, and thrombin has been shown to increase the permeability of endothelial cell monolayers. Therefore, we suspected that thrombin affects airway permeability. Calu-3 cell monolayers were established on microporous membranes of tissue culture cell inserts. We examined the effects of topically applied thrombin or thrombin receptor-activating peptide (TRAP) on: (1) transepithelial permeability (luminal to serosal transfer) of radiolabeled mannitol and albumin, (2) changes in electrical resistance, and (3) actin fiber content as assessed by fluorescence microscopy. Compared with untreated control cultures, treatment of the monolayers for 24 h with thrombin or TRAP significantly decreased the electrical resistance and increased the permeability to mannitol and albumin. In addition, these treatments enhanced the appearance of actin stress fibers, and small gaps became visible at areas of cell-cell contact. Thrombin appears to increase epithelial permeability by receptor-mediated reorganization of the actin network in airway epithelial cells. This is likely to contribute to the impairment of the airway barrier function. Copyright 2006 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16282712     DOI: 10.1159/000089718

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  7 in total

1.  Increased thrombin-activatable fibrinolysis inhibitor levels in patients with chronic rhinosinusitis with nasal polyps.

Authors:  Yoshimasa Imoto; Atsushi Kato; Tetsuji Takabayashi; Whitney Stevens; James E Norton; Lydia A Suh; Roderick G Carter; Ava R Weibman; Kathryn E Hulse; Kathleen E Harris; Anju T Peters; Leslie C Grammer; Bruce K Tan; Kevin Welch; Stephanie Shintani-Smith; David B Conley; Robert C Kern; Shigeharu Fujieda; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2019-09-25       Impact factor: 10.793

Review 2.  The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications.

Authors:  Silvio Danese; Stefania Vetrano; Li Zhang; Victoria A Poplis; Francis J Castellino
Journal:  Blood       Date:  2009-12-17       Impact factor: 22.113

Review 3.  Control of cell adhesion dynamics by Rap1 signaling.

Authors:  Benjamin Boettner; Linda Van Aelst
Journal:  Curr Opin Cell Biol       Date:  2009-07-16       Impact factor: 8.382

Review 4.  Gene Therapy for Acute Respiratory Distress Syndrome.

Authors:  Jing Liu; David A Dean
Journal:  Front Physiol       Date:  2022-01-17       Impact factor: 4.566

5.  KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions.

Authors:  Angela Glading; Jaewon Han; Rebecca A Stockton; Mark H Ginsberg
Journal:  J Cell Biol       Date:  2007-10-22       Impact factor: 10.539

Review 6.  Chronic Rhinosinusitis and the Coagulation System.

Authors:  Dong Young Kim; Seong H Cho; Tetsuji Takabayashi; Robert P Schleimer
Journal:  Allergy Asthma Immunol Res       Date:  2015-05-12       Impact factor: 5.764

7.  Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019.

Authors:  Saravanan Subramaniam; Wolfram Ruf; Markus Bosmann
Journal:  Br J Pharmacol       Date:  2021-07-07       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.